IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.180
-0.120 (-9.23%)
At close: Aug 13, 2025, 4:00 PM
1.160
-0.020 (-1.69%)
After-hours: Aug 13, 2025, 6:00 PM EDT
IRIDEX Market Cap
IRIDEX has a market cap or net worth of $19.81 million as of August 13, 2025. Its market cap has decreased by -38.67% in one year.
Market Cap
19.81M
Enterprise Value
20.12M
1-Year Change
-38.67%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since December 1, 1998, IRIDEX's market cap has decreased from $26.00M to $19.81M, a decrease of -23.80%. That is a compound annual growth rate of -1.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 21.20M | -24.01% |
Dec 31, 2024 | 27.90M | -38.95% |
Dec 29, 2023 | 45.70M | 42.37% |
Dec 30, 2022 | 32.10M | -66.87% |
Dec 31, 2021 | 96.90M | 177.65% |
Dec 31, 2020 | 34.90M | 13.68% |
Dec 31, 2019 | 30.70M | -51.96% |
Dec 31, 2018 | 63.90M | -27.55% |
Dec 29, 2017 | 88.20M | -38.19% |
Dec 30, 2016 | 142.70M | 54.44% |
Dec 31, 2015 | 92.40M | 9.22% |
Dec 31, 2014 | 84.60M | -15.15% |
Dec 31, 2013 | 99.70M | 184.86% |
Dec 31, 2012 | 35.00M | 4.48% |
Dec 30, 2011 | 33.50M | -4.83% |
Dec 31, 2010 | 35.20M | 29.41% |
Dec 31, 2009 | 27.20M | 262.67% |
Dec 31, 2008 | 7.50M | -65.28% |
Dec 31, 2007 | 21.60M | -68.92% |
Dec 29, 2006 | 69.50M | 18.00% |
Dec 30, 2005 | 58.90M | 88.18% |
Dec 31, 2004 | 31.30M | -17.41% |
Dec 31, 2003 | 37.90M | 89.50% |
Dec 31, 2002 | 20.00M | -38.46% |
Dec 31, 2001 | 32.50M | - |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |